GeneFerm Biotechnology Co., Ltd. (TPEX:1796)
40.00
+1.00 (2.50%)
Mar 10, 2026, 12:31 PM CST
GeneFerm Biotechnology Balance Sheet
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | 280.26 | 122.45 | 120.15 | 100.69 | 539.61 | Upgrade
|
| Cash & Short-Term Investments | 280.26 | 122.45 | 120.15 | 100.69 | 539.61 | Upgrade
|
| Cash Growth | 128.88% | 1.91% | 19.33% | -81.34% | 55.05% | Upgrade
|
| Accounts Receivable | 97.93 | 101.56 | 117.6 | 120.98 | 104.66 | Upgrade
|
| Other Receivables | 15.83 | 15.22 | 0.15 | 0.46 | 0.24 | Upgrade
|
| Receivables | 113.76 | 116.78 | 117.75 | 121.44 | 104.9 | Upgrade
|
| Inventory | 190.23 | 165.87 | 155.43 | 142.61 | 114.83 | Upgrade
|
| Prepaid Expenses | 11.23 | 6.87 | 3.8 | 8.81 | 5.84 | Upgrade
|
| Total Current Assets | 595.48 | 411.97 | 397.13 | 373.54 | 765.18 | Upgrade
|
| Property, Plant & Equipment | 663.58 | 708.46 | 761.95 | 734.28 | 510.39 | Upgrade
|
| Other Intangible Assets | 1.16 | 1.7 | 2.02 | 1.1 | 1.4 | Upgrade
|
| Long-Term Deferred Tax Assets | 9.88 | 14.37 | 8.87 | 8.66 | 7.7 | Upgrade
|
| Other Long-Term Assets | 10.55 | 9.99 | 5.41 | 72.05 | 32.22 | Upgrade
|
| Total Assets | 1,281 | 1,146 | 1,175 | 1,190 | 1,317 | Upgrade
|
| Accounts Payable | 16.15 | 23.77 | 33.2 | 49.93 | 39.08 | Upgrade
|
| Accrued Expenses | - | 46.71 | 58.39 | 51.9 | 40.95 | Upgrade
|
| Short-Term Debt | - | - | 40 | 45 | - | Upgrade
|
| Current Portion of Long-Term Debt | 33.16 | 24.43 | 5.25 | 26 | 308.65 | Upgrade
|
| Current Portion of Leases | 6.26 | 5.42 | 6.04 | 5.97 | 5.19 | Upgrade
|
| Current Income Taxes Payable | 1.82 | - | 19.01 | 10.28 | 13.42 | Upgrade
|
| Current Unearned Revenue | 23.95 | 12.49 | 5.78 | 7.63 | 8.29 | Upgrade
|
| Other Current Liabilities | 77.31 | 21.43 | 22.18 | 42.52 | 15.6 | Upgrade
|
| Total Current Liabilities | 158.64 | 134.26 | 189.86 | 239.22 | 431.18 | Upgrade
|
| Long-Term Debt | 205.38 | 126.54 | - | 5.25 | 31.25 | Upgrade
|
| Long-Term Leases | 79.44 | 78.53 | 76.15 | 98.8 | 92.13 | Upgrade
|
| Pension & Post-Retirement Benefits | - | 18.88 | 16.52 | 15.59 | 14.66 | Upgrade
|
| Long-Term Deferred Tax Liabilities | 0.01 | 0.1 | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 20.53 | 0.01 | 0.01 | 0.01 | 0.01 | Upgrade
|
| Total Liabilities | 464 | 358.31 | 282.54 | 358.86 | 569.22 | Upgrade
|
| Common Stock | 414.6 | 414.6 | 414.6 | 414.6 | 407.89 | Upgrade
|
| Additional Paid-In Capital | 294.34 | 294.34 | 294.34 | 294.34 | 270.69 | Upgrade
|
| Retained Earnings | 109.84 | 81.38 | 186.69 | 124.26 | 72.27 | Upgrade
|
| Comprehensive Income & Other | -2.11 | -2.13 | -2.79 | -2.43 | -3.19 | Upgrade
|
| Shareholders' Equity | 816.66 | 788.18 | 892.84 | 830.77 | 747.66 | Upgrade
|
| Total Liabilities & Equity | 1,281 | 1,146 | 1,175 | 1,190 | 1,317 | Upgrade
|
| Total Debt | 324.23 | 234.92 | 127.44 | 181.02 | 437.22 | Upgrade
|
| Net Cash (Debt) | -43.97 | -112.47 | -7.29 | -80.33 | 102.39 | Upgrade
|
| Net Cash Per Share | -1.07 | -2.71 | -0.18 | -1.89 | 2.21 | Upgrade
|
| Filing Date Shares Outstanding | 40.55 | 41.46 | 41.46 | 41.46 | 40.79 | Upgrade
|
| Total Common Shares Outstanding | 40.55 | 41.46 | 41.46 | 41.46 | 40.79 | Upgrade
|
| Working Capital | 436.85 | 277.71 | 207.27 | 134.32 | 334 | Upgrade
|
| Book Value Per Share | 20.14 | 19.01 | 21.53 | 20.04 | 18.33 | Upgrade
|
| Tangible Book Value | 815.5 | 786.48 | 890.82 | 829.67 | 746.27 | Upgrade
|
| Tangible Book Value Per Share | 20.11 | 18.97 | 21.49 | 20.01 | 18.30 | Upgrade
|
| Land | - | 15.44 | 15.44 | 15.44 | 15.44 | Upgrade
|
| Buildings | - | 457.26 | 260.87 | 259.44 | 255.46 | Upgrade
|
| Machinery | - | 825.29 | 822.26 | 725.62 | 536.67 | Upgrade
|
| Construction In Progress | - | - | 194.02 | 184.12 | 127.34 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.